Can a Alaska resident get peptides by telehealth?
AS 08.64.364 allows an Alaska-licensed physician to prescribe, dispense, or administer a prescription drug without conducting a physical examination if the physician or a similar practitioner is available for follow-up care and the standard of care is met; the 2016 amendments (SB 74) removed the earlier requirement that the physician be physically located in Alaska. HB 265 (2022) added AS 08.01.085, which lets any Alaska-licensed health care provider deliver telehealth to a patient in Alaska, and the Division of Corporations, Business and Professional Licensing publishes telehealth guidance for each board. Providers must hold an Alaska license (there is no out-of-state registration exception for physicians), and any business delivering distance health care to Alaska patients must register on the Telemedicine Business Registry. Physicians and physician assistants may prescribe controlled substances by telehealth if they comply with AS 08.64.364 and federal law. The statutes do not require a real-time video encounter for non-controlled drugs, so asynchronous evaluation followed by a prescription is not prohibited as long as the documented evaluation meets the standard of care. [5] [6]
How does the Alaska pharmacy board treat compounding?
| Board | Alaska Board of Pharmacy |
|---|---|
| Eligible substances | Follows the federal 503A framework |
The Alaska Board of Pharmacy regulates pharmacy practice under AS 08.80 and 12 AAC 52; rule 12 AAC 52.440 requires a pharmacy or pharmacist that compounds to follow the Board's "Compounding Practices" guidelines pamphlet dated February 2008, which the rule incorporates by reference, and rule 12 AAC 52.430 requires a pharmacy that prepares or dispenses sterile pharmaceuticals (which includes injectable peptides) to adhere to the accepted standard of care. Alaska has no state bulks list, so peptide eligibility follows the federal 503A framework. Since November 27, 2023, the nonresident registration statute (AS 08.80.158) has been repealed and every pharmacy shipping prescription drugs into Alaska, wherever located, must hold an Alaska pharmacy license under AS 08.80.157 with a licensed pharmacist-in-charge. A telehealth prescription filled by an out-of-state pharmacy that has not obtained the Alaska license is being dispensed unlawfully. The Alaska Administrative Code text of 12 AAC 52.440 published by the Alaska Legislature, checked 2026-09-22, still incorporates the February 2008 pamphlet, so the rule has not been rewritten since the 2023 licensing changes. [1] [2] [3] [4] [7]
Can you get compounded GLP-1s in Alaska?
Because Alaska now requires a full pharmacy license for any out-of-state pharmacy, Alaska patients using telehealth GLP-1 programs should confirm the dispensing pharmacy appears in the Division's professional license search as an Alaska-licensed pharmacy. [1] [2] [10]
Prices by channel: semaglutide cost, tirzepatide cost.
Approvals, shortage history, and prices for every GLP-1 we track are on the GLP-1 hub.
What is the legal access path in Alaska?
Verified access options
Prescriber licensed in Alaska, in person or by telehealth
Telehealth prescribing of non-controlled peptides is permitted in Alaska. Asynchronous (questionnaire or messaging) prescribing is permitted when it meets the standard of care.
Pharmacy licensed or registered with the Alaska Board of Pharmacy
Check the dispensing pharmacy against the board's license lookup before paying, including out-of-state mail-order pharmacies.
Branded GLP-1 through a retail or manufacturer pharmacy
FDA approved semaglutide and tirzepatide are available by prescription. Compounded GLP-1 limited; see the GLP-1 section for why.
Access paths are verified against public regulatory records and prescriber licensing. We never list unlicensed vendors.
Find a provider in Alaska
Is it legal to buy research peptides in Alaska?
Any entity distributing prescription drugs into Alaska must be licensed by the Board of Pharmacy under AS 08.80.157, and peptides sold "for research use only" but marketed for human injection are unapproved new drugs under 21 U.S.C. 331 regardless of labeling. These products are not dispensed by a pharmacist, are not covered by Alaska's Telemedicine Business Registry protections, and carry no state consumer safeguards. [2] [11]
Peptide-specific notes for Alaska
No peptide-specific rule identified for this jurisdiction. The general compounding and telehealth rules above apply, and the federal record covers semaglutide, tirzepatide, and BPC-157.
Frequently asked questions
Can I get a GLP-1 prescription in Alaska through telehealth without a physical exam?
Yes. AS 08.64.364 lets an Alaska-licensed physician prescribe a drug without a physical examination if follow-up care is available and the standard of care is met, and AS 08.01.085 extends telehealth authority to other Alaska-licensed providers. Semaglutide and tirzepatide are not controlled substances, so no additional in-person requirement applies. [5] [6]
Does an out-of-state telehealth clinic need an Alaska license to treat me?
Yes. The provider must hold an Alaska license from the relevant board, and the business must be listed on Alaska's Telemedicine Business Registry. Alaska does not offer a telehealth-only registration for physicians licensed elsewhere. [5] [6]
Can a mail-order pharmacy in another state ship compounded peptides to Alaska?
Only if it holds an Alaska pharmacy license. Since November 27, 2023, the nonresident registration under AS 08.80.158 no longer exists and all pharmacies serving Alaska patients are licensed under AS 08.80.157 with an Alaska-registered pharmacist-in-charge. Search the Division's professional license database before ordering. [1] [2]
Can an Alaska pharmacy compound BPC-157 or other unapproved peptides?
No, not from bulk today. BPC-157 is not on the 503A bulks list. PCAC's July 2026 recommendation is advisory, and until FDA publishes a final rule a 503A pharmacy has no federal basis to compound it from bulk. State boards cannot authorize what federal law does not. Peptides still in FDA Category 2 cannot be compounded either. [3] [8] [9]
Sources
Numbered citations above point to these primary sources: the state statute or rule, the pharmacy board, and federal FDA guidance.
- [1]Alaska Board of Pharmacy (Division of Corporations, Business and Professional Licensing)
- [2]Alaska Board of Pharmacy: statutes and regulations (AS 08.80 and 12 AAC 52, including the 2023 pharmacy licensing changes)
- [3]12 AAC 52.440, Guidelines relating to compounding practices
- [4]Alaska Legislature, Alaska Administrative Code: 12 AAC 52.430 (sterile pharmaceuticals) and 12 AAC 52.440 (compounding practices), accessed 2026-09-22
- [5]Alaska Statutes AS 08.64.364, Prescribing without a physical examination (telehealth), as amended by SB 74 (2016)
- [6]Alaska Division of Corporations, Business and Professional Licensing: telehealth information and Telemedicine Business Registry (AS 08.01.085)
- [7]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA
- [8]FDA: Certain bulk drug substances for use in compounding may present significant safety risks (503A and 503B category lists)FDA
- [9]FDA: Pharmacy Compounding Advisory CommitteeFDA
- [10]FDA: concerns with unapproved GLP-1 drugs used for weight loss, including shortage resolution and compounding grace periodsFDA
- [11]21 U.S.C. 331, Prohibited acts
Cite this page
Free to cite and quote with a link. Data is licensed CC BY 4.0 with attribution to PeptideAgent.
- APA style
PeptideAgent. (2026, September 22). Are peptides legal in Alaska?. https://peptideagent.ai/legal/alaska- HTML link
<a href="https://peptideagent.ai/legal/alaska">Are peptides legal in Alaska?</a>, PeptideAgent, updated September 22, 2026.